disulfanilamide has been researched along with dapsone in 1 studies
*Dapsone: A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) [MeSH]
*Dapsone: A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) [MeSH]
| Studies (disulfanilamide) | Trials (disulfanilamide) | Recent Studies (post-2010) (disulfanilamide) | Studies (dapsone) | Trials (dapsone) | Recent Studies (post-2010) (dapsone) |
|---|---|---|---|---|---|
| 18 | 0 | 0 | 5,116 | 379 | 862 |
| Protein | Taxonomy | disulfanilamide (IC50) | dapsone (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 0.42 | |
| Dihydrofolate reductase | Pneumocystis carinii | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnetblanc, JM; Bordessoule, D; Liozon, F; Loustaud, V; Michel, JP; Vidal, E; Weinbreck, P | 1 |
1 other study(ies) available for disulfanilamide and dapsone
| Article | Year |
|---|---|
[Disulon in the treatment of Horton's disease. Experience with 20 patients].
Topics: Aged; Aged, 80 and over; Dapsone; Drug Evaluation; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Sulfanilamides | 1986 |